Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Hasyanee Binmaeil, Alfizah Hanafiah, Isa Mohamed Rose & Raja Affendi Raja Ali. (2021) Development and Validation of Multiplex Quantitative PCR Assay for Detection of Helicobacter pylori and Mutations Conferring Resistance to Clarithromycin and Levofloxacin in Gastric Biopsy. Infection and Drug Resistance 14, pages 4129-4145.
Read now
Read now
Samin Alihosseini, Reza Ghotaslou, Fatemah Sadeghpour Heravi, Zainab Ahmadian & Hamed Ebrahimzadeh Leylabadlo. (2020) Management of antibiotic-resistant Helicobacter pylori infection: current perspective in Iran. Journal of Chemotherapy 32:6, pages 273-285.
Read now
Read now
Mohammad-Hossein Haddadi, Babak Negahdari, Roya Asadolahi & Abdollah Bazargani. (2020) Helicobacter pylori antibiotic resistance and correlation with cagA motifs and homB gene. Postgraduate Medicine 132:6, pages 512-520.
Read now
Read now
Mara Di Giulio, Emanuela Di Campli, Soraya Di Bartolomeo, Valentina Cataldi, Leonardo Marzio, Laurino Grossi, Antonio Francesco Ciccaglione, Antonia Nostro & Luigina Cellini. (2016) In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. Scandinavian Journal of Gastroenterology 51:3, pages 263-269.
Read now
Read now
Yang Yang, Ruizhuo Ouyang, Lina Xu, Ning Guo, Weiwei Li, Kai Feng, Lei Ouyang, Zhuoyuan Yang, Shuang Zhou & Yuqing Miao. (2015) Review: Bismuth complexes: synthesis and applications in biomedicine. Journal of Coordination Chemistry 68:3, pages 379-397.
Read now
Read now
K Vekens, S Vandebosch, A De Bel, D Urbain & F Mana. (2013) PRIMARY ANTIMICROBIAL RESISTANCE OF HELICOBACTER PYLORI IN BELGIUM. Acta Clinica Belgica 68:3, pages 183-187.
Read now
Read now
Articles from other publishers (77)
Faezeh Kiani, Sara Khademolhosseini, Jasem Mohammadi, Arian Tavasol, Ramtin Hajibeygi, Mobina Fathi & Majid Dousti. (2024) Novel Information Regarding the Treatment of Helicobacter pylori Infection:
A Systematic Review and Meta-analysis of Randomized Clinical Trials. Current Reviews in Clinical and Experimental Pharmacology 19:2, pages 184-203.
Crossref
Crossref
Mohammad Abavisani & Masoud Keikha. (2023) Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysis. Annals of Clinical Microbiology and Antimicrobials 22:1.
Crossref
Crossref
Zachary C Junga, Andrew Mertz, Kevin Pak & Manish Singla. (2023)
Helicobacter pylori
Treatment Regimen Selection and Eradication Rates Across Department of Defense Patients for Fiscal Years 2016-2018
. Military Medicine 188:7-8, pages e2089-e2095.
Crossref
Crossref
Boram Han, Hyo Jung Kim, Ho-Young Yhim, Doyeun Oh, Sung Hwa Bae, Ho-Jin Shin, Won-Sik Lee, JiHyun Kwon, Jeong-Ok Lee, Hwa Jung Kim & Soo-Mee Bang. (2022) Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study. Annals of Hematology 101:7, pages 1435-1445.
Crossref
Crossref
Nader Nemr, Rania M. Kishk, Ayman Salem, Mohamed O. Abdalla, Noha M. Abd El-Fadeal & Nashaat M. Soliman. (2022) Genotypic detection of metronidazole and clarithromycin resistance in dyspeptic patients with helicobacter pylori. Environmental Science and Pollution Research 29:27, pages 41467-41474.
Crossref
Crossref
Miguel Gallardo Padilla, José Luis León Falconi, Rafael Sánchez-Nebreda Arias, Carmen Gómez Santos, María del Carmen Muñoz Egea & Enrique la Orden Izquierdo. (2022) Impacto del uso de las técnicas moleculares (PCR) en la detección y el éxito erradicador frente a Helicobacter pylori. Anales de Pediatría 96:3, pages 190-195.
Crossref
Crossref
Miguel Gallardo Padilla, José Luis León Falconi, Rafael Sánchez-Nebreda Arias, Carmen Gómez Santos, María del Carmen Muñoz Egea & Enrique la Orden Izquierdo. (2022) Impact of the use of molecular techniques (PCR) on detection and eradication success against Helicobacter pylori. Anales de Pediatría (English Edition) 96:3, pages 190-195.
Crossref
Crossref
Kiwon Shin, Min-Jae Cho, Jung-Hwan Oh & Chul-Hyun Lim. (2021) Second-Line Bismuth-Containing Quadruple Therapy for Helicobacterpylori Infection: A 12-Year Study of Annual Eradication Rates. Journal of Clinical Medicine 10:15, pages 3273.
Crossref
Crossref
Su Young Kim & Jun-Won Chung. (2020) Best Helicobacter pylori Eradication Strategy in the Era of Antibiotic Resistance. Antibiotics 9:8, pages 436.
Crossref
Crossref
Kichul Yoon, Nayoung Kim, Jung Won Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park & Dong Ho Lee. (2020)
Annual eradication rate of bismuth‐containing quadruple therapy as second‐line treatment for
Helicobacter pylori
infection: A 15‐year prospective study at a tertiary hospital in Korea
. Helicobacter 25:3.
Crossref
Crossref
Zohreh Bari, Hafez Fakheri, Tarang Taghvaei & Mohammad Yaghoobi. (2020)
A Comparison between 10-day and 12-day Concomitant Regimens for
Helicobacter Pylori
Eradication: A Randomized Clinical Trial
. Middle East Journal of Digestive Diseases 12:2, pages 106-110.
Crossref
Crossref
Marcelo Oporto, Monica Pavez, Claudia Troncoso, Alvaro Cerda, Edmundo Hofmann, Armando Sierralta, Eddy Rios, Luis Coppelli & Leticia Barrientos. (2019) Prevalence of Infection and Antibiotic Susceptibility of Helicobacter pylori: An Evaluation in Public and Private Health Systems of Southern Chile. Pathogens 8:4, pages 226.
Crossref
Crossref
Antonio Francesco Ciccaglione, Luigina Cellini & Leonardo Marzio. (2019)
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first‐line treatment of
Helicobacter pylori
infection: Two pilot studies
. Helicobacter 24:5.
Crossref
Crossref
Monica Contreras, Lucie Benejat, Heisser Mujica, Jessy Peña, María-Alexandra García-Amado, Fabian Michelangeli & Philippe Lehours. (2019) Real-time PCR detection of a 16S rRNA single mutation of Helicobacter pylori isolates associated with reduced susceptibility and resistance to tetracycline in the gastroesophageal mucosa of individual hosts. Journal of Medical Microbiology 68:9, pages 1287-1291.
Crossref
Crossref
Shweta Mahant, Amresh Kumar Sharma, Valentina Gehlot, Asish Kumar Mukhopadhyay, Ayushi Chhawchharia, Sangitanjan Dutta, Anil Agarwal, Anup Som, Kunal Das & Rajashree Das. (2019) Geographically Distinct North-East Indian Helicobacter pylori Strains are Highly Sensitive to Clarithromycin but are Levofloxacin Resistant. Indian Journal of Medical Microbiology 37:3, pages 337-344.
Crossref
Crossref
Emad M. Eed, Yousry A. Hawash, Amany S. Khalifa, Khalaf F. Alsharif, Saleh A. Alghamdi, Taisir Saber, Khadiga A. Ismail & Somaia A. Shehab‐Eldeen. (2019)
Molecular diagnosis of
Helicobacter pylori
antibiotic resistance in the Taif region, Saudi Arabia
. Microbiology and Immunology 63:6, pages 199-205.
Crossref
Crossref
Bekir Kocazeybek, Merve Kutlu Sakli, Pelin Yuksel, Mehmet Demirci, Reyhan Caliskan, Tevhide Ziver Sarp, Suat Saribas, Suleyman Demiryas, Fatma Kalayci, Huseyin Cakan, Hayriye Kirkoyun Uysal, Nesrin Gareayaghi, Sevgi Ergin, Yusuf Ziya Erzin, Kadir Bal, İhsan Tascı & Hrisi Bahar Tokman. (2019) Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance. Journal of Medical Microbiology 68:4, pages 566-573.
Crossref
Crossref
Antonio Francesco Ciccaglione, Mara Di Giulio, Silvia Di Lodovico, Emanuela Di Campli, Luigina Cellini & Leonardo Marzio. (2019)
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of
Helicobacter pylori
infection: an
in vitro
and
in vivo
study
. Journal of Antimicrobial Chemotherapy 74:4, pages 1069-1077.
Crossref
Crossref
Kichul YoonNayoung Kim. (2019)
Eradication Rates of 10-day Sequential Therapy for
Helicobacter pylori
: Results of an 8-year Prospective Study Conducted at a Tertiary Korean Hospital
. The Korean Journal of Gastroenterology 73:2, pages 99.
Crossref
Crossref
Sung Eun KimJi Hun RohMoo In Park, Seun Ja ParkWon MoonJae Hyun KimKyoungwon JungJae Joon Heo. (2019)
Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line
Helicobacter pylori
Eradication Therapy
. The Korean Journal of Gastroenterology 73:1, pages 26.
Crossref
Crossref
Kyoung Hwa Lee, Soon Young ParkSu Jin JeongDa Hyun JungJie-Hyun KimSeok Hoon JeongIl-Mo Kang & Young Goo Song. (2019)
Can Aminoglycosides Be Used as a New Treatment for
Helicobacter pylori
?
In vitro
Activity of Recently Isolated
Helicobacter pylori
. Infection & Chemotherapy 51:1, pages 10.
Crossref
Crossref
Hyasinta Jaka, Jee Ah. Rhee, Linda Östlundh, Luke Smart, Robert Peck, Andreas Mueller, Christa Kasang & Stephen E. Mshana. (2018) The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: systematic review and meta-analysis. BMC Infectious Diseases 18:1.
Crossref
Crossref
Da Hyun Jung, Jie-Hyun Kim, Su Jin Jeong, Soon Young Park, Il-Mo Kang, Kyoung Hwa Lee & Young Goo Song. (2018)
Peptide Nucleic Acid Probe-Based Analysis as a New Detection Method for Clarithromycin Resistance in
Helicobacter pylori
. Gut and Liver 12:6, pages 641-647.
Crossref
Crossref
Manal Diab, Ahmed El-Shenawy, Maged El-Ghannam, Dalia Salem, Moustafa Abdelnasser, Mohamed Shaheen, Mahmoud Abdel-Hady, Effat El-Sherbini & Mohamed Saber. (2018) Detection of antimicrobial resistance genes of Helicobacter pylori strains to clarithromycin, metronidazole, amoxicillin and tetracycline among Egyptian patients. Egyptian Journal of Medical Human Genetics 19:4, pages 417-423.
Crossref
Crossref
Fayaz Ahmad Wani, Gulnaz Bashir, Mushtaq Ahmad Khan, Showkat Ali Zargar, Zubaida Rasool & Qurteeba Qadri. (2018) Antibiotic Resistance in Helicobacter pylori: A Mutational Analysis from a Tertiary Care Hospital in Kashmir, India. Indian Journal of Medical Microbiology 36:2, pages 265-272.
Crossref
Crossref
Sun Min Lee, Nayoung Kim, Yong Hwan Kwon, Ryoung Hee Nam, Jung Mogg Kim, Jong Youn Park, Yeon Suk Lee & Dong Ho Lee. (2018)
rdxA, frxA
, and efflux pump in metronidazole-resistant
Helicobacter pylori
: Their relation to clinical outcomes
. Journal of Gastroenterology and Hepatology 33:3, pages 681-688.
Crossref
Crossref
Jae Yong ParkJae Gyu Kim. (2018)
New
Helicobacter pylori
Eradication Therapies
. The Korean Journal of Gastroenterology 72:5, pages 237.
Crossref
Crossref
Soohoon KwonDong Ho LeeJae Bin KangNayoung KimYoung Soo ParkCheol Min ShinHyuk YoonYoon Jin Choi. (2018)
The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in
Helicobacter pylori
Eradication
. The Korean Journal of Gastroenterology 71:4, pages 196.
Crossref
Crossref
Hafez Fakheri, Mehdi Saberi Firoozi & Zohreh Bari. (2017) Eradication of Helicobacter Pylori in Iran: A Review. Middle East Journal of Digestive Diseases 10:1, pages 5-17.
Crossref
Crossref
Lyudmila Boyanova, Galina Gergova, Rumyana Markovska, Nayden Kandilarov, Lyubomir Davidkov, Zoya Spassova & Ivan Mitov. (2017) Primary Helicobacter pylori resistance in elderly patients over 20 years: A Bulgarian study. Diagnostic Microbiology and Infectious Disease 88:3, pages 264-267.
Crossref
Crossref
Soohoon KwonDong Ho LeeJae Bin KangNayoung KimYoung Soo ParkCheol Min ShinHyuk YoonYoon Jin Choi. (2017)
The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in
Helicobacter pylori
Eradication
. The Korean Journal of Gastroenterology 70:2, pages 72.
Crossref
Crossref
Shira I. Doron, Kirthana R. Beaulac, Abhay Dhand & David R. Snydman. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
281
287
.
Ju Yup Lee, Nayoung Kim, Kyung Sik Park, Hyun Jin Kim, Seon Mee Park, Gwang Ho Baik, Ki-Nam Shim, Jung Hwan Oh, Suck Chei Choi, Sung Eun Kim, Won Hee Kim, Seon-Young Park, Gwang Ha Kim, Bong Eun Lee, Yunju Jo & Su Jin Hong. (2016) Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial. BMC Gastroenterology 16:1.
Crossref
Crossref
Antonio Francesco Ciccaglione, Roberta Tavani, Laurino Grossi, Luigina Cellini, Lamberto Manzoli & Leonardo Marzio. (2016)
Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of
Helicobacter pylori
Infection: Two Pilot Studies
. Helicobacter 21:5, pages 375-381.
Crossref
Crossref
Valentina Gehlot, Shweta Mahant, Asish Kumar Mukhopadhyay, Kunal Das, Jawed Alam, Prachetash Ghosh & Rajashree Das. (2016) Low prevalence of clarithromycin-resistant Helicobacter pylori isolates with A2143G point mutation in the 23S rRNA gene in North India. Journal of Global Antimicrobial Resistance 6, pages 39-43.
Crossref
Crossref
Tomahisa Uchida, Ratha-korn Vilaichone, Supakarn Chaithongrat, Pornpen Gamnarai, Thawee Ratanachu-ek, Varocha Mahachai & Yoshio Yamaoka. (2016) Extremely High Prevalence of Metronidazole-Resistant Helicobacter pylori Strains in Mountain People (Karen and Hmong) in Thailand. The American Journal of Tropical Medicine and Hygiene 94:4, pages 717-720.
Crossref
Crossref
I. Thung, H. Aramin, V. Vavinskaya, S. Gupta, J. Y. Park, S. E. Crowe & M. A. Valasek. (2016)
Review article: the global emergence of
Helicobacter pylori
antibiotic resistance
. Alimentary Pharmacology & Therapeutics 43:4, pages 514-533.
Crossref
Crossref
Robin B. Harris, Eyal Oren, David Bui & Heidi E. Brown. (2016) Serologic Evidence for Fecal–Oral Transmission of Helicobacter pylori. The American Journal of Tropical Medicine and Hygiene 94:1, pages 82-88.
Crossref
Crossref
Ju Yup Lee & Kyung Sik Park. (2016)
Optimal First-Line Treatment for
Helicobacter pylori
Infection: Recent Strategies
. Gastroenterology Research and Practice 2016, pages 1-7.
Crossref
Crossref
Ju Yup Lee. 2016. Helicobacter pylori. Helicobacter pylori
437
445
.
Ju Yup Lee. 2016. Helicobacter pylori. Helicobacter pylori
427
436
.
Sun Min Lee. 2016. Helicobacter pylori. Helicobacter pylori
405
413
.
Yong Hwan Kwon. 2016. Helicobacter pylori. Helicobacter pylori
387
396
.
Nuno Almeida, Maria Manuel Donato, José Manuel Romãozinho, Cristina Luxo, Olga Cardoso, Maria Augusta Cipriano, Carol Marinho, Alexandra Fernandes, Carlos Calhau & Carlos Sofia. (2015) Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?. BMC Gastroenterology 15:1.
Crossref
Crossref
Teresa Fasciana, Cinzia Calà, Celestino Bonura, Enza Di Carlo, Domenica Matranga, Giuseppe Scarpulla, Michele Manganaro, Salvatore Camilleri & Anna Giammanco. (2015) Resistance to clarithromycin and genotypes in Helicobacter pylori strains isolated in Sicily. Journal of Medical Microbiology 64:11, pages 1408-1414.
Crossref
Crossref
Hafez Fakheri, Zeinab Bakhshi, Zohreh Bari & Saman Alhooei. (2015) Effects of Clarithromycin-Containing Quadruple Therapy on Helicobacter Pylori Eradication after Nitroimidazole-Containing Quadruple Therapy Failure. Middle East Journal of Digestive Diseases 8:1, pages 51-6.
Crossref
Crossref
Antonio Francesco Ciccaglione, Luigina Cellini, Laurino Grossi, Lamberto Manzoli & Leonardo Marzio. (2015)
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of
Helicobacter pylori
Infection: A Pilot Study
. Helicobacter 20:5, pages 390-396.
Crossref
Crossref
Kichul Yoon, Nayoung Kim, Ryoung H Nam, Ji H Suh, Seonmin Lee, Jung M Kim, Ju Y Lee, Yong H Kwon, Yoon J Choi, Hyuk Yoon, Cheol M Shin, Young S Park & Dong H Lee. (2015)
Ultimate eradication rate of
Helicobacter pylori
after first, second, or third-line therapy in Korea
. Journal of Gastroenterology and Hepatology 30:3, pages 490-495.
Crossref
Crossref
Laura K. Greenfield, Frances Dang & Nicola L. Jones. 2014. Autophagy, Infection, and the Immune Response. Autophagy, Infection, and the Immune Response
171
200
.
Constanza M Camargo, Apolinaria García, Arnoldo Riquelme, William Otero, Claudia A Camargo, Tomas Hernandez-García, Roberto Candia, Michael G Bruce & Charles S Rabkin. (2014) The Problem of Helicobacter pylori Resistance to Antibiotics: A Systematic Review in Latin America. American Journal of Gastroenterology 109:4, pages 485-495.
Crossref
Crossref
Ju Yup LeeNayoung Kim. (2014)
Future Trends of
Helicobacter pylori
Eradication Therapy in Korea
. The Korean Journal of Gastroenterology 63:3, pages 158.
Crossref
Crossref
Hafez Fakheri. (2014)
Helicobacter pylori
eradication in West Asia: A review
. World Journal of Gastroenterology 20:30, pages 10355.
Crossref
Crossref
Vasilios Papastergiou. (2014)
Treatment of
Helicobacter pylori
infection: Meeting the challenge of antimicrobial resistance
. World Journal of Gastroenterology 20:29, pages 9898.
Crossref
Crossref
Emad Yahaghi, Faham Khamesipour, Fatemeh Mashayekhi, Farhad Safarpoor Dehkordi, Mohammad Hossein Sakhaei, Mojtaba Masoudimanesh & Maryam Khayyat Khameneie. (2014)
Helicobacter pylori
in Vegetables and Salads: Genotyping and Antimicrobial Resistance Properties
. BioMed Research International 2014, pages 1-11.
Crossref
Crossref
Abdoulaye Seck, Christophe Burucoa, Daouda Dia, Mouhamadou Mbengue, Manuella Onambele, Josette Raymond & Sebastien Breurec. (2013) Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients. Annals of Clinical Microbiology and Antimicrobials 12:1.
Crossref
Crossref
Ratha-korn Vilaichone, Pornpen Gumnarai, Thawee Ratanachu-ek & Varocha Mahachai. (2013) Nationwide survey of Helicobacter pylori antibiotic resistance in Thailand. Diagnostic Microbiology and Infectious Disease 77:4, pages 346-349.
Crossref
Crossref
Rebecca Smiley, James Bailey, Mahadevan Sethuraman, Norberto Posecion & M. Showkat Ali. (2013) Comparative proteomics analysis of sarcosine insoluble outer membrane proteins from clarithromycin resistant and sensitive strains of Helicobacter pylori. Journal of Microbiology 51:5, pages 612-618.
Crossref
Crossref
Bryan H Schmitt, MaryAnn Regner, Kathy A Mangold, Richard B Thomson Jr & Karen L Kaul. (2013) PCR detection of clarithromycin-susceptible and -resistant Helicobacter pylori from formalin-fixed, paraffin-embedded gastric biopsies. Modern Pathology 26:9, pages 1222-1227.
Crossref
Crossref
Peng Su, Youming Li, Hongzhang Li, Jiakun Zhang, Lang Lin, Qunying Wang, Feng Guo, Zizhong Ji, Jibo Mao, Wuheng Tang, Zhengchao Shi, Wei Shao, Junliang Mao, Xinjian Zhu, Xiaofeng Zhang, Yuefeng Tong, Huimin Tu, Mizu Jiang, Zhiyong Wang, Fengzhe Jin, Ningmin Yang & Jianzhong Zhang. (2013)
Antibiotic Resistance of
Helicobacter Pylori
Isolated in the Southeast Coastal Region of China
. Helicobacter 18:4, pages 274-279.
Crossref
Crossref
Marwa S. Fathi, Runia Fouad EL-Folly, Rania Ahmed Hassan & Mohammed Ezz El-Arab. (2013) Genotypic and phenotypic patterns of antimicrobial susceptibility of Helicobacter pylori strains among Egyptian patients. Egyptian Journal of Medical Human Genetics 14:3, pages 235-246.
Crossref
Crossref
Gita Eslami, Soudabeh Taheri, Neda Baseri, Seyed Ali Montazeri, Abdolvahid Shakeri, Roghayeh Samadi, Hosein Dabiri, Zahra Zahirnia & Azanollah Azargashb. (2012) Prevalence of Helicobacter pylori and Determination of Antibiotic Resistance in Patients with Gastritis Referred to Shahid Beheshti University of Medical Sciences Hospitals in Tehran Between 2010 and 2011. Archives of Clinical Infectious Diseases 8:1, pages 18-22.
Crossref
Crossref
Rodrigo Buzinaro Suzuki, Cristiane Maria Almeida & Márcia Aparecida Sperança. (2012) Absence of Helicobacter pylori high tetracycline resistant 16S rDNA AGA926-928TTC genotype in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil. BMC Gastroenterology 12:1.
Crossref
Crossref
C. Y. Tay, H. M. Windsor, F. Thirriot, W. Lu, C. Conway, T. T. Perkins & B. J. Marshall. (2012)
Helicobacter pylori
eradication in Western Australia using novel quadruple therapy combinations
. Alimentary Pharmacology & Therapeutics 36:11-12, pages 1076-1083.
Crossref
Crossref
M. Gasparetto, M. Pescarin & G. Guariso. (2012)
Helicobacter pylori
Eradication Therapy: Current Availabilities
. ISRN Gastroenterology 2012, pages 1-8.
Crossref
Crossref
Metin Küçükazman, Ayse Kefeli, Sebahat Basyigit, Abdullah Özgür Yeniova, Yasar Nazligül, Ibrahim Halil Akkus, Ayla Tezer & Servet Guresci. (2017) Efficacy of Bismuth-Containing Quadruple Therapy as
First-line Treatment for Helicobacter pylori Infection. Euroasian Journal of Hepato-Gastroenterology 2:2, pages 90-93.
Crossref
Crossref
Javier P. Gisbert. (2012)
Rescue Therapy for
Helicobacter pylori
Infection 2012
. Gastroenterology Research and Practice 2012, pages 1-12.
Crossref
Crossref
Maria Pina Dore, Vincenza Tadeu, Bianca Are, Ida Mura, Giuseppe Fanciulli, Giovannino Massarelli & Andrea Piana. (2012)
Efficacy of a “Rescue” Ciprofloxacin-Based Regimen for Eradication of
Helicobacter pylori
Infection after Treatment Failures
. Gastroenterology Research and Practice 2012, pages 1-5.
Crossref
Crossref
Lyudmila Boyanova, Juliana Ilieva, Galina Gergova, Lubomir Davidkov, Zoya Spassova, Victor Kamburov, Nikolai Katsarov & Ivan Mitov. (2012) Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study. Journal of Medical Microbiology 61:1, pages 85-93.
Crossref
Crossref
Amin Talebi Bezmin Abadi, Tarang Taghvaei, Ashraf Mohabbati Mobarez, Beth M. Carpenter & D. Scott Merrell. (2011) Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran. The Journal of Microbiology 49:6, pages 987-993.
Crossref
Crossref
Michael Selgrad & Peter Malfertheiner. (2011) Treatment of Helicobacter pylori. Current Opinion in Gastroenterology 27:6, pages 565-570.
Crossref
Crossref
Guodong Liu, Xiwei Xu, Lihua He, Zhaolu Ding, Yixin Gu, Jianzhong Zhang & Liya Zhou. (2011) Primary Antibiotic Resistance of Helicobacter pylori Isolated from Beijing Children. Helicobacter 16:5, pages 356-362.
Crossref
Crossref
Collise Njume, Afolayan A. Jide & Roland N. Ndip. (2011) Aqueous and Organic Solvent-Extracts of Selected South African Medicinal Plants Possess Antimicrobial Activity against Drug-Resistant Strains of Helicobacter pylori: Inhibitory and Bactericidal Potential. International Journal of Molecular Sciences 12:9, pages 5652-5665.
Crossref
Crossref
Véronique Yvette Miendje Deyi, Alain Burette, Zahra Bentatou, Younes Maaroufi, Patrick Bontems, Philippe Lepage & Marijke Reynders. (2011) Practical use of GenoType® HelicoDR, a molecular test for Helicobacter pylori detection and susceptibility testing. Diagnostic Microbiology and Infectious Disease 70:4, pages 557-560.
Crossref
Crossref
Vincenzo De Francesco. (2011)
Mechanisms of
Helicobacter pylori
antibiotic resistance: An updated appraisal
. World Journal of Gastrointestinal Pathophysiology 2:3, pages 35.
Crossref
Crossref
J.-C. Yang, P.-I. Lee & P.-R. Hsueh. (2010) In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998–2007. European Journal of Clinical Microbiology & Infectious Diseases 29:11, pages 1369-1375.
Crossref
Crossref
Irina Kalbina, Lars Engstrand, Sören Andersson & Åke Strid. (2010)
Expression of
Helicobacter pylori
TonB Protein in Transgenic
Arabidopsis thaliana
: Toward Production of Vaccine Antigens in Plants
. Helicobacter 15:5, pages 430-437.
Crossref
Crossref
Lyudmila Boyanova, Rossen Nikolov, Galina Gergova, Ivailo Evstatiev, Elena Lazarova, Victor Kamburov, Emilia Panteleeva, Zoya Spassova & Ivan Mitov. (2010) Two-decade trends in primary Helicobacter pylori resistance to antibiotics in Bulgaria. Diagnostic Microbiology and Infectious Disease 67:4, pages 319-326.
Crossref
Crossref